Increased INR w/ vit K antagonists eg, warfarin or fluindione. Ezetimibe: Decreased absorption rate w/ antacids. Decreased mean AUC w/ cholestyramine. Increased mean AUC w/ cyclosporine. Severe myositis & myoglobinuria w/ fibrates. Increased total conc w/ fenofibrate, gemfibrozil. Rosuvastatin: Increased AUC w/ cyclosporine, atazanavir/ritonavir, simeprevir, lopinavir/ritonavir, clopidogrel, gemfibrozil, eltrombopag, darunavir/ritonavir, tipranavir/ritonavir, dronedarone, itraconazole, ezetimibe. Decreased AUC w/ erythromycin, baicalin. Decreased plasma conc w/ Al- & Mg hydroxide-containing antacid susp. Muscle-related events eg, rhabdomyolysis w/ fusidic acid. Increased risk of myopathy w/ gemfibrozil, fenofibrate & other fibrates eg, nicotinic acid; daptomycin.